Molecular mechanisms of epilepsy

Nature Neuroscience

Volumn 18, Issue 3, 2015, Pages 367-372

  Staley, Kevin ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BICARBONATE; BIOLOGICAL MARKER; CHLORIDE; GROWTH FACTOR; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; SODIUM CHANNEL; SOMATOMEDIN;

ALEXANDER DISEASE; ARTICLE; BRAIN MALFORMATION; CHRONIC DISEASE; CORTICAL DYSPLASIA; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; EPILEPSY; EPILEPTIC DISCHARGE; EPILEPTOGENESIS; GABAERGIC SYSTEM; GENE MUTATION; HUMAN; INTRACTABLE EPILEPSY; LOSS OF FUNCTION MUTATION; MEMBRANE CONDUCTANCE; NERVE CELL PLASTICITY; NEUROLOGIC DISEASE; NEURONAL CEROID LIPOFUSCINOSIS; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEIZURE; SEVERE MYOCLONIC EPILEPSY IN INFANCY; SYNAPTIC TRANSMISSION; TUBEROUS SCLEROSIS; ANIMAL; BRAIN; GENETICS; NERVE CELL INHIBITION; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; EPILEPSY; HUMANS; NEURAL INHIBITION; SEIZURES;

EID: 84923697997     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.3947     Document Type: Article

References (82)

1. Matsumoto, H. & Ajmonemarsan, C. Cellular mechanisms in experimental epileptic seizures. Science 144, 193-194 (1964).
2. Prince, D.A. & Wilder, B.J. Control mechanisms in cortical epileptogenic foci. "Surround" inhibition. Arch. Neurol. 16, 194-202 (1967).
3. Walther, H., Lambert, J.D., Jones, R.S., Heinemann, U. & Hamon, B. Epileptiform activity in combined slices of the hippocampus, subiculum and entorhinal cortex during perfusion with low magnesium medium. Neurosci. Lett. 69, 156-161 (1986).
4. Wiechert, P. & Herbst, A. Provocation of cerebral seizures by derangement of the natural balance between glutamic acid and γ-aminobutyric acid. J. Neurochem. 13, 59-64 (1966).
5. Croucher, M.J., Collins, J.F. & Meldrum, B.S. Anticonvulsant action of excitatory amino acid antagonists. Science 216, 899-901 (1982).
6. Scharfman, H.E. The neurobiology of epilepsy. Curr. Neurol. Neurosci. Rep. 7, 348-354 (2007).
7. Jett, D.A. Chemical toxins that cause seizures. Neurotoxicology 33, 1473-1475 (2012).
8. Boison, D. Methylxanthines, seizures, and excitotoxicity. Handb. Exp. Pharmacol. 200, 251-266 (2011).
9. Moran, N.F. et al. Epilepsy in the United Kingdom: seizure frequency and severity, anti-epileptic drug utilization and impact on life in 1,652 people with epilepsy. Seizure 13, 425-433 (2004).
10. Macdonald, R.L. & Kang, J.Q. mRNA surveillance and endoplasmic reticulum quality control processes alter biogenesis of mutant GABAA receptor subunits associated with genetic epilepsies. Epilepsia 53 (suppl. 9), 59-70 (2012).
11. Yu, F.H. et al. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat. Neurosci. 9, 1142-1149 (2006).
12. Carvill, G.L. et al. GABRA1 and STXBP1: novel genetic causes of Dravet syndrome. Neurology 82, 1245-1253 (2014).
13. Ran, X. et al. EpilepsyGene: a genetic resource for genes and mutations related to epilepsy. Nucleic Acids Res. doi:10.1093/nar/gku943 (2014).
14. Epi4K Consortium & Epilepsy Phenome/Genome Project. De novo mutations in epileptic encephalopathies. Nature 501, 217-221 (2013).
15. Veeramah, K.R. et al. Exome sequencing reveals new causal mutations in children with epileptic encephalopathies. Epilepsia 54, 1270-1281 (2013).
16. Weckhuysen, S. et al. KCNQ2 Study Group. Extending the KCNQ2 encephalopathy spectrum: clinical and neuroimaging findings in 17 patients. Neurology 81, 1697-1703 (2013).
17. Zhang, W. et al. Surviving hilar somatostatin interneurons enlarge, sprout axons, and form new synapses with granule cells in a mouse model of temporal lobe epilepsy. J. Neurosci. 29, 14247-14256 (2009).
18. Buckmaster, P.S. Does mossy fiber sprouting give rise to the epileptic state? Adv. Exp. Med. Biol. 813, 161-168 (2014).
19. Sutula, T.P. & Dudek, F.E. Unmasking recurrent excitation generated by mossy fiber sprouting in the epileptic dentate gyrus: an emergent property of a complex system. Prog. Brain Res. 163, 541-563 (2007).
20. Ferini-Strambi, L., Sansoni, V. & Combi, R. Nocturnal frontal lobe epilepsy and the acetylcholine receptor. Neurologist 18, 343-349 (2012).
21. Herzog, A.G. Catamenial epilepsy: definition, prevalence pathophysiology and treatment. Seizure 17, 151-159 (2008).
22. Lopes da Silva, F. et al. Epilepsies as dynamical diseases of brain systems: basic models of the transition between normal and epileptic activity. Epilepsia 44 (suppl. 12), 72-83 (2003).
23. Jirsa, V.K., Stacey, W.C., Quilichini, P.P., Ivanov, A.I. & Bernard, C. On the nature of seizure dynamics. Brain 137, 2210-2230 (2014).
24. Bracci, E., Vreugdenhil, M., Hack, S.P. & Jefferys, J.G. Dynamic modulation of excitation and inhibition during stimulation at gamma and beta frequencies in the CA1 hippocampal region. J. Neurophysiol. 85, 2412-2422 (2001).
25. Patenaude, C., Massicotte, G. & Lacaille, J.C. Cell-type specific GABA synaptic transmission and activity-dependent plasticity in rat hippocampal stratum radiatum interneurons. Eur. J. Neurosci. 22, 179-188 (2005).
26. Wester, J.C. & McBain, C.J. Behavioral state-dependent modulation of distinct interneuron subtypes and consequences for circuit function. Curr. Opin. Neurobiol. 29C, 118-125 (2014).
27. Morimoto, K., Fahnestock, M. & Racine, R.J. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog. Neurobiol. 73, 1-60 (2004).
28. Valentine, M., Keddie, K.M. & Dunne, D. A comparison of techniques in electroconvulsive therapy. Br. J. Psychiatry 114, 989-996 (1968).
29. Le Duigou, C., Holden, T. & Kullmann, D.M. Short- and long-term depression at glutamatergic synapses on hippocampal interneurons by group I mGluR activation. Neuropharmacology 60, 748-756 (2011).
30. Jane, D.E., Lodge, D. & Collingridge, G.L. Kainate receptors: pharmacology, function and therapeutic potential. Neuropharmacology 56, 90-113 (2009).
31. Méndez, P. & Bacci, A. Assortment of GABAergic plasticity in the cortical interneuron melting pot. Neural Plast. 2011, 976856 (2011).
32. Kaeser, P.S. & Regehr, W.G. Molecular mechanisms for synchronous, asynchronous, and spontaneous neurotransmitter release. Annu. Rev. Physiol. 76, 333-363 (2014).
33. Rajakulendran, S., Kaski, D. & Hanna, M.G. Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS. Nat. Rev. Neurol. 8, 86-96 (2012).
34. Lazarevic, V., Pothula, S., Andres-Alonso, M. & Fejtova, A. Molecular mechanisms driving homeostatic plasticity of neurotransmitter release. Front. Cell. Neurosci. 7, 244 (2013).
35. Casillas-Espinosa, P.M., Powell, K.L. & O'Brien, T.J. Regulators of synaptic transmission: roles in the pathogenesis and treatment of epilepsy. Epilepsia 53 (suppl. 9), 41-58 (2012).
36. Meier, J.C., Semtner, M., Winkelmann, A. & Wolfart, J. Presynaptic mechanisms of neuronal plasticity and their role in epilepsy. Front. Cell. Neurosci. 8, 164 (2014).
37. Letts, V.A. et al. The mouse stargazer gene encodes a neuronal Ca2+-channel gamma subunit. Nat. Genet. 19, 340-347 (1998).
38. Yokoi, N., Fukata, M. & Fukata, Y. Synaptic plasticity regulated by protein-protein interactions and posttranslational modifications. Int. Rev. Cell Mol. Biol. 297, 1-43 (2012).
39. Fukata, Y. et al. Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science 313, 1792-1795 (2006).
40. Goodkin, H.P., Joshi, S., Mtchedlishvili, Z., Brar, J. & Kapur, J. Subunit-specific trafficking of GABA(A) receptors during status epilepticus. J. Neurosci. 28, 2527-2538 (2008).
41. Naylor, D.E., Liu, H., Niquet, J. & Wasterlain, C.G. Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus. Neurobiol. Dis. 54, 225-238 (2013).
42. Kovács, R. et al. Endogenous nitric oxide is a key promoting factor for initiation of seizure-like events in hippocampal and entorhinal cortex slices. J. Neurosci. 29, 8565-8577 (2009).
43. Chang, P., Walker, M.C. & Williams, R.S. Seizure-induced reduction in PIP3 levels contributes to seizure-activity and is rescued by valproic acid. Neurobiol. Dis. 62, 296-306 (2014).
44. Fisher, R.S., Pedley, T.A., Moody, W.J. Jr. & Prince, D.A. The role of extracellular potassium in hippocampal epilepsy. Arch. Neurol. 33, 76-83 (1976).
45. Staley, K.J., Soldo, B.L. & Proctor, W.R. Ionic mechanisms of neuronal excitation by inhibitory GABAA receptors. Science 269, 977-981 (1995).
46. Ransom, C.B., Ransom, B.R. & Sontheimer, H. Activity-dependent extracellular K+ accumulation in rat optic nerve: the role of glial and axonal Na + pumps. J. Physiol. (Lond.) 522, 427-442 (2000).
47. Raimondo, J.V. et al. A genetically-encoded chloride and pH sensor for dissociating ion dynamics in the nervous system. Front. Cell. Neurosci. 7, 202 (2013).
48. Deng, H., Xiu, X. & Song, Z. The molecular biology of genetic-based epilepsies. Mol. Neurobiol. 49, 352-367 (2014).
49. Heinemann, U., Konnerth, A., Pumain, R. & Wadman, W.J. Extracellular calcium and potassium concentration changes in chronic epileptic brain tissue. Adv. Neurol. 44, 641-661 (1986).
50. Kovács, R., Kardos, J., Heinemann, U. & Kann, O. Mitochondrial calcium ion and membrane potential transients follow the pattern of epileptiform discharges in hippocampal slice cultures. J. Neurosci. 25, 4260-4269 (2005).
51. Macdonald, R.L. & Botzlakis, E.J. in Physiology and Pathology of Chloride Transporters and Channels in the Nervous System (eds. Alvarez-Leefmans, F. & Delpire, E.) Ch. 14, 257-282 (Elsevier, London, 2009).
52. Staley, K.J. & Proctor, W.R. Modulation of mammalian dendritic GABA(A) receptor function by the kinetics of Cl - and HCO3- transport. J. Physiol. (Lond.) 519, 693-712 (1999).
53. Kahle, K.T. et al. Roles of the cation-chloride cotransporters in neurological disease. Nat. Clin. Pract. Neurol. 4, 490-503 (2008).
54. Larsen, B.R. et al. Contributions of the Na+/K+-ATPase, NKCC1, and Kir4.1 to hippocampal K+ clearance and volume responses. Glia 62, 608-622 (2014).
55. Lillis, K.P., Kramer, M.A., Mertz, J., Staley, K.J. & White, J.A. Pyramidal cells accumulate chloride at seizure onset. Neurobiol. Dis. 47, 358-366 (2012).
56. Albensi, B.C., Oliver, D.R., Toupin, J. & Odero, G. Electrical stimulation protocols for hippocampal synaptic plasticity and neuronal hyper-excitability: are they effective or relevant? Exp. Neurol. 204, 1-13 (2007).
57. Bertram, E. The relevance of kindling for human epilepsy. Epilepsia 48 (suppl. 2), 65-74 (2007).
58. Prince, D.A., Parada, I. & Graber, K. in Jasper's Basic Mechanisms of the Epilepsies [Internet] 4th edn. (eds. Noebels, J.L. et al.) Ch. 24, 315-321 (National Center for Biotechnology Information, Bethesda, Maryland, 2012).
59. Heinzen, E.L. et al. ATP1A3 Working Group. Distinct neurological disorders with ATP1A3 mutations. Lancet Neurol. 13, 503-514 (2014).
60. Vaillend, C., Mason, S.E., Cuttle, M.F. & Alger, B.E. Mechanisms of neuronal hyperexcitability caused by partial inhibition of Na+-K+-ATPases in the rat CA1 hippocampal region. J. Neurophysiol. 88, 2963-2978 (2002).
61. Guerrini, R. & Dobyns, W.B. Malformations of cortical development: clinical features and genetic causes. Lancet Neurol. 13, 710-726 (2014).
62. Mirzaa, G.M. & Poduri, A. Megalencephaly and hemimegalencephaly: breakthroughs in molecular etiology. Am. J. Med. Genet. C. Semin. Med. Genet. 166C, 156-172 (2014).
63. Berdichevsky, Y. et al. PI3K-Akt signaling activates mTOR-mediated epileptogenesis in organotypic hippocampal culture model of post-traumatic epilepsy. J. Neurosci. 33, 9056-9067 (2013).
64. Lasarge, C.L. & Danzer, S.C. Mechanisms regulating neuronal excitability and seizure development following mTOR pathway hyperactivation. Front. Mol. Neurosci. 7, 18 (2014).
65. Wong, M. A critical review of mTOR inhibitors and epilepsy: from basic science to clinical trials. Expert Rev. Neurother. 13, 657-669 (2013).
66. Buckmaster, P.S. & Lew, F.H. Rapamycin suppresses mossy fiber sprouting but not seizure frequency in a mouse model of temporal lobe epilepsy. J. Neurosci. 31, 2337-2347 (2011).
67. Gardiner, J. & Marc, J. Disruption of normal cytoskeletal dynamics may play a key role in the pathogenesis of epilepsy. Neuroscientist 16, 28-39 (2010).
68. McNamara, J.O., Huang, Y.Z. & Leonard, A.S. Molecular signaling mechanisms underlying epileptogenesis. Sci. STKE 2006, re12 (2006).
69. Fernández, E., Rajan, N. & Bagni, C. The FMRP regulon: from targets to disease convergence. Front. Neurosci. 7, 191 (2013).
70. Na, E.S., Nelson, E.D., Kavalali, E.T. & Monteggia, L.M. The impact of MeCP2 loss- or gain-of-function on synaptic plasticity. Neuropsychopharmacology 38, 212-219 (2013).
71. Marsh, E.D. & Golden, J.A. in Jasper's Basic Mechanisms of the Epilepsies [Internet] 4th edn. (eds. Noebels, J.L. et al.) Ch. 63, 813-823 (National Center for Biotechnology Information, Bethesda, Maryland, 2012).
72. Kato, M. & Dobyns, W.B. X-linked lissencephaly with abnormal genitalia as a tangential migration disorder causing intractable epilepsy: proposal for a new term, interneuronopathy. J. Child Neurol. 20, 392-397 (2005).
73. Southwell, D.G. et al. Interneurons from embryonic development to cell-based therapy. Science 344, 1240622 (2014).
74. O'Leary, T. & Wyllie, D.J. Neuronal homeostasis: time for a change? J. Physiol. (Lond.) 589, 4811-4826 (2011).
75. Frey, L.C. Epidemiology of posttraumatic epilepsy: a critical review. Epilepsia 44 (suppl. 10), 11-17 (2003).
76. Volman, V., Bazhenov, M. & Sejnowski, T.J. Pattern of trauma determines the threshold for epileptic activity in a model of cortical deafferentation. Proc. Natl. Acad. Sci. USA 108, 15402-15407 (2011).
77. Turrigiano, G.G., Leslie, K.R., Desai, N.S., Rutherford, L.C. & Nelson, S.B. Activity-dependent scaling of quantal amplitude in neocortical neurons. Nature 391, 892-896 (1998).
78. Carvill, G.L. et al. GRIN2A mutations cause epilepsy-aphasia spectrum disorders. Nat. Genet. 45, 1073-1076 (2013).
79. Ogiwara, I. et al. Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J. Neurosci. 27, 5903-5914 (2007).
80. Liu, Y. et al. Dravet syndrome patient-derived neurons suggest a novel epilepsy mechanism. Ann. Neurol. 74, 128-139 (2013).
81. Girard, J.M., Turnbull, J., Ramachandran, N. & Minassian, B.A. Progressive myoclonus epilepsy. Handb. Clin. Neurol. 113, 1731-1736 (2013).
82. Chabrol, B., Caillaud, C. & Minassian, B. Neuronal ceroid lipofuscinoses. Handb. Clin. Neurol. 113, 1701-1706 (2013).